Oral presentations 2: Pharmacoepidemiology
Tracks
Track 2
Wednesday, December 10, 2025 |
9:00 AM - 10:30 AM |
Speaker
Dr George Tan
Research Fellow
Monash University
Prescription sequence symmetry analysis of glucagon-like peptide-1 receptor agonist and neuropsychiatric conditions
Biography
George is a Research Fellow in Pharmacoepidemiology and Real-world Evidence at the Centre for Medicine Use and Safety, Monash University. His research focuses on generating real-world evidence on medication use patterns and outcomes. George has a specific interest in generating and validating drug repurposing hypotheses using real-world data. George currently serves as the Deputy Chair of the ASCEPT Pharmacoepidemiology SIG. George also teaches undergraduate and postgraduate topics such as Medication Safety, Evidence-based Practice, as well as coordinating the Objective Structured Clinical Examinations (OSCEs). He is also a practising pharmacist, with experience in both community and hospital pharmacy.
Dr Kenji Fujita
Postdoctoral Research Fellow
Kolling Institute
Drug Burden Index–guided stewardship intervention to deprescribe in Older Acute Inpatients
Biography
Dr. Kenji Fujita is a Postdoctoral Research Fellow at the Laboratory of Ageing and Pharmacology, Kolling Institute, University of Sydney. His research focuses on evaluating interventions for deprescribing inappropriate polypharmacy in older inpatients, developing a multidomain frailty index using routinely collected clinical data, and investigating the impact of deprescribing on physical functions in older mice with polypharmacy using neural network models. Since 2020, he has served as the working group co-lead on guidelines and indicators within the Pharmaceutical Care Network Europe (PCNE). With expertise in big data analysis, epidemiology, statistical modelling, and web application development, he has co-led a Japanese government funded project developing and validating quality indicators for community pharmacies (2024-2026).
Mr Edward Chun Yin Lau
Phd Candidate
Sydney Pharmacy School, The University Of Sydney
Clusters of psychotropic and health service use in people with dementia
Biography
Edward is a community pharmacist in Australia and PhD student at the University of Sydney with a research interest in pharmacoepidemiology in older people, especially people living with dementia in community settings in Australia. He is particularly interested in the prevalence, risk factors and outcomes of high-risk prescribing in this population. His research is aimed at improving the safety and effectiveness of medication use in people living with dementia.
Dr Edwin Tan
Senior Lecturer
The University Of Sydney
Mapping multimorbidity clusters in older Australians using linked administrative health data
Biography
Dr Edwin Tan is a Dementia Australia Mid-Career Research Fellow and Senior Lecturer at the School of Pharmacy, Faculty of Medicine and Health, University of Sydney. He is a registered pharmacist with clinical experience in both Australia and the UK. He chairs the ASCEPT Pharmacoepidemiology Special Interest Group, co-chairs the ADNeT EMCR Accelerator Group and co-leads the Pharmaceutical Policy Node, Charles Perkins Centre. His research interests include geriatric pharmacy, pharmacoepidemiology, medication safety and personalised medicine.
Ms Toni Michael
Pharmacology PhD Student
The University Of Sydney
Age-stratified trends in Australian prescribing of controlled ovarian hyperstimulation medications between 2016-2024
Biography
Toni is a PhD student from the School of Pharmacy at the University of Sydney. Her research is on understanding the pharmacodynamic, pharmacokinetic, and pharmacogenomic properties of commonly prescribed fertility mediations to inform optimal use of medications in practice.
Ms Ilsa Wojt
Phd Candidate
University Of Sydney
Incidence and profiles of poisonings in older people with dementia in Sweden
Biography
Ilsa Wojt is a hospital pharmacist and PhD candidate at the University of Sydney, focusing on pharmacoepidemiology and medication safety in older adults. Her research focuses on dementia, real world data, and poisoning risk, using large-scale registry data to describe real-world evidence that helps inform best practice. Alongside her academic work, as a hospital pharmacist, she has a strong interest in the societal dimensions of medication safety, including how health systems, caregiving structures, and social contexts shape risks and outcomes for older adult and behavioural health outcomes. Her broader research aim is to advance safe, effective, and person-centred medication use in vulnerable populations.
